The Safety and Regulatory Bulletin.
An editorial feed of the regulatory, supply, and safety updates that matter to practicing clinicians. Edited weekly by the Editorial Director; reviewed by pharmacology faculty before publication.
Want these in your inbox? Registered members can opt in from the notification preferences page.
Recent Notes
The most recent bulletin entries, in reverse chronological order.
Editorial Feed
- April 14 FDA Compounding Update A summary of the latest compounding guidance that touches peptide therapy, with a pointer to the primary document and a note on what changes in day-to-day practice.
- March 31 Adulteration Advisory: GHRP-2 Sourcing An advisory on recent reports of adulterated GHRP-2 product reaching the market through non-pharmacy channels, with practical sourcing guidance.
- March 17 Interaction Watch: GLP-1 Receptor Agonists and Anesthesia A reminder of current anesthesia-society guidance on peri-operative GLP-1 agonist holding, and the unresolved questions that remain.
Submit a Note
Practicing clinicians: if you have seen something in the field that belongs in the bulletin, write to safety@omicpathways.org. We review every submission and publish under faculty review where warranted.